T2 Biosystems Reports Preliminary Q3 Results; Achieves Total Revenue Of $1.5M, Decrease Of 60% From Prior Year
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems has reported preliminary Q3 results, with total revenue of $1.5M, a decrease of 60% from the prior year.
October 12, 2023 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
T2 Biosystems' Q3 revenue has decreased by 60% compared to the same period last year.
The significant decrease in revenue is a negative indicator for the company's financial performance. This could potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100